Myocardial Perfusion CMR for Differentiating and Characterizing Hypertrophic Cardiomyopathy Phenotypes | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Myocardial Perfusion CMR for Differentiating and Characterizing Hypertrophic Cardiomyopathy Phenotypes	Amyloid Neuropathies, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, Cerebral Small Vessel Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Fabry disease, Lipid Metabolism Disorders, Lipid Metabolism, Inborn Errors, Lysosomal Storage Diseases, Nervous System, Nutritional and Metabolic Diseases, X-linked disease, amyloidosis, aortic valve disorder, aortic valve stenosis, brain disorder, cardiomyopathy, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, familial amyloid neuropathy, heart disorder, heart valve disorder, hereditary amyloidosis, hereditary disease, hypertrophic cardiomyopathy, inborn errors of metabolism, inherited neurodegenerative disorder, lysosomal lipid storage disorder, lysosomal storage disease, metabolic disease, nervous system disorder, neurodegenerative disease, neuromuscular disease, peripheral nervous system disorder, proteostasis deficiencies, sphingolipidosis, subvalvular aortic stenosis, vascular disorder	Recruiting	Not stated	2026-02-02		NCT07382128

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
IRCCS Azienda Ospedaliero-Universitaria di Bologna	331

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
IRCCS Azienda Ospedaliero-Universitaria di Bologna	Bologna	Italy	1